Germany's Merck KGaA said on Tuesday its lab equipment division and its pharmaceuticals division would be under new ...

For many years, the pharmaceutical business concentrated mostly on blockbuster medications, which are cures for common ...

The latest example of this trend is Merck KGaA’s impending all-cash acquisition of SpringWorks Therapeutics, valued around ...

Significantly extends commercial reach of Growth Direct through expanded global sales channels; enables opportunities for ...

Peter Guenter will retire as CEO of Merck KGaA’s healthcare business on June 1, one of several personnel moves that the German pharma announced earlier ...

Merck KGaA , the German healthcare and technology group, said on Monday it is in advanced talks to acquire U.S. cancer and rare diseases drugmaker SpringWorks Therapeutics . Germany's Merck in ...

Merck KGaA’s U.S. pharma arm has recruited actor Selma Blair for a collaboration around multiple sclerosis treatment Mavenclad. | No cruel intentions here: Merck KGaA’s U.S. pharma arm has recruited ...

UBS analyst Matthew Weston maintained a Buy rating on Merck KGaA (0O14 – Research Report) today and set a price target of €190.00. The ...

FRANKFURT, Feb 18 (Reuters) - Germany's Merck KGaA (MRCG.DE), opens new tab said on Tuesday its lab equipment division and its pharmaceuticals division would be under new leadership from June but ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

today announced that it has entered into a five-year global distribution and collaboration agreement (the “Agreement”) with the Life Science business of Merck KGaA , Darmstadt, Germany ...